Clinical testing of a new compound that has promise as a new prescription drug cannot begin until a(n) ______ is submitted to Health Canada.

Question

Quizplus · Accepted Answer

A CTA (Clinical Trial Application) must be submitted to Health Canada before clinical testing of a new compound can begin. This application includes information on the compound's safety, efficacy, and proposed methodology for clinical trials. Options B and C are not relevant to the initial regulatory process of beginning clinical trials.

Clinical Testing of a New Compound That Has Promise as a New